Skip to content
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
The 15th International Conference On Malignant Lymphoma (ICML) was held in Lugano, Switzerland, from 18 – 22 June 2019. ICML 2019 brought together the world’s professionals in lymphoma to discuss the cutting-edge updates from hot topics across lymphoma disciplines.
Highlights covered chemo-free regimens, the latest trial data, and CAR T-cell discussions. The diseases explored included Hodgkin lymphoma and non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and follicular lymphoma (FL). Chronic lymphocytic leukemia (CLL) was also a focus of the meeting.
CAR T-Cells
With new advances constantly on the horizon, CAR T-cell therapy against lymphoma was an exciting topic at ICML 2019.
Find out more about the latest CAR T-cell therapies, including toxicity data and management, and what the world-leading experts think about the future of CAR-T for lymphoma and CLL.
View more
Trial Updates
Clinical trials are an essential part of understanding and measuring the progress of new therapies.
Discover more on the latest clinical data presented at ICML 2019, including results from MANTLE-FIRST, PHOENIX and CheckMate 205.
View more